Dr. Kelsey Martin, dean of the David Geffen School of Medicine at UCLA, has been appointed by California Gov. Jerry Brown to the Governor’s Advisory Committee on Precision Medicine.
The 14-member committee will advise the governor's office on emerging precision medicine policy issues, such as data sharing and data privacy within and across technology platforms and tools; clinical utility of precision medicine approaches to care; patient and provider engagement and education; and economic impact and sustainability of precision medicine-based treatments. The committee will also provide recommendations on further actions the public and private sectors can take to integrate precision medicine into health care.
"California is a world leader in medicine and technology. This committee of experts will help us think through how precision medicine can improve health and health care for Californians," Brown said.
The advisory committee members represent a range of expertise necessary in precision medicine: biotechnology, technology, health systems, health disparities, population health, cancer, bioinformatics, ethics, genomics and patient engagement.
As dean of the David Geffen School of Medicine at UCLA, Martin is committed to research and collaboration in and among all of these areas.
Further, earlier this year, UCLA and the David Geffen School of Medicine launched the Institute for Precision Health at UCLA, which will facilitate current and future large-scale initiatives in genetic and genomic medicine; create new, currently untapped, opportunities for innovative discovery; and further solidify UCLA’s international leadership in a broad range of scholarship and training, information technology and clinical care.